Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.5K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinctive MRI features of the epileptogenic zone in children with tuberous sclerosis.

European journal of radiology·2014
Same author

Treatment strategies.

Handbook of clinical neurology·2013
Same author

Predictors of seizure freedom after incomplete resection in children.

Neurology·2010
Same author

Incomplete resection of focal cortical dysplasia is the main predictor of poor postsurgical outcome.

Neurology·2008
Same author

Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.

Neurology·2004
Same author

Infantile spasms: unique syndrome or general age-dependent manifestation of a diffuse encephalopathy?

International review of neurobiology·2002

Related Experiment Video

Updated: Mar 16, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K

Childhood Epilepsy : Current Therapeutic Recommendations.

J T Gilman1,2, M Duchowny1

  • 1Department of Neuroscience and Comprehensive Epilepsy Center, Miami Children's Hospital, Miami, Florida, USA.

CNS Drugs
|August 14, 2016
PubMed
Summary

Pediatric epilepsy pharmacotherapy requires unique considerations due to developmental differences and distinct drug toxicities. More research is needed for effective, safe antiepileptic drug treatments in children.

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.8K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K

Related Experiment Videos

Last Updated: Mar 16, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.8K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacology

Background:

  • Childhood epilepsies often stem from developmental or genetic factors, differing from adult-onset conditions.
  • Treatment indications for antiepileptic drugs (AEDs) in children vary, with some syndromes resolving without medication.
  • Serious childhood epilepsy syndromes or those with brain damage necessitate prompt pharmacological intervention.

Purpose of the Study:

  • To highlight the unique challenges in pediatric epilepsy pharmacotherapy.
  • To emphasize the need for tailored treatment approaches considering age-specific efficacy and tolerability.
  • To underscore the urgency for dedicated pediatric AED research.

Main Methods:

  • Review of existing literature on childhood epilepsy pharmacotherapy.
  • Comparison of AED efficacy and tolerability profiles in pediatric populations.
  • Analysis of pharmacokinetic and pharmacodynamic differences between children and adults.

Main Results:

  • Pediatric epilepsy pharmacotherapy must address developmental and genetic underpinnings.
  • AED selection requires careful balancing of efficacy against age-specific adverse effects, particularly neurodevelopmental toxicity.
  • Pediatric-specific challenges include altered drug metabolism, gastrointestinal transit, and potential for toxic metabolite accumulation.

Conclusions:

  • Current pediatric epilepsy treatment recommendations often rely on adult data and anecdotal evidence.
  • There is a critical need for robust clinical trials to establish evidence-based pediatric AED guidelines.
  • Optimizing AED therapy in children requires understanding unique pharmacokinetic and toxicity profiles.